Книга Клетка "на диете". Научное открытие о влиянии жиров на мышление, физическую активность и обмен веществ - Джозеф Меркола

22. J. Moore, Keto Clarity (Victory Belt Publishing, 2014), 58.

23. A. J. Brown, “Low-Carb Diets, Fasting and Euphoria: Is There a Link between Ketosis and Gamma-hydroxybutyrate (GHB)?” Medical Hypotheses, 68, no. 2 (2007): 268-71, DOI: 10.1016/j.mehy.2006.07.043.

Глава 3

1. E. L. Knight et al., “The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency,” Annals of Internal Medicine, 138. no. 6 (2003): 460-67, DOI: 10.7326/0003-4819-138-6-200303180-00009.

2. M. I. Frisard et al., “Effect of 6-Month Calorie Restriction on Biomarkers of Longevity, Metabolic Adaptation, and Oxidative Stress in Overweight Individuals: A Randomized Controlled Trial,” http://jamanetwork.com/journals/jama/fullarti-cle/1108368.

3. M. E. Levine et al., “Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population,” Cell Metabolism, 19, no. 3 (2014): 407-17, DOI: 10.1016/j. cmet.2014.02.006.

4. J. Guevara-Aguirre et al., “Growth Hormone Receptor Deficiency Is Associated With a Major Reduction in Pro-aging Signaling, Cancer and Diabetes in Humans,” Science Translational Medicine, 3, no. 70 (2011): 70, DOI: 10.1126/ scitranslmed.3001845.

5. S. I. A. Apelo and D. W. Lamming, “Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island,” Journal of Gerontology, 71, no. 7 (2016): 841–849, DOI: 10.1093/gerona/glw090.

6. S. M. Solon-Biet et al., “The Ratio of Macronutrients, Not Caloric Intake, Dictates Cardiometabolic Health, Aging, and Longevity in Ad Libi-tum-Fed Mice,” Cell Metabolism, 19, no. 3 (2014): 418-30, DOI: 10.1016/j. cmet.2014.02.009.

Глава 4

1. “Ferritin: The Test,” American Association for Clinical Chemistry, https://labtest-sonline.org/understanding/analytes/ferritin/tab/test/, accessed May 9, 2016.

2. E. D. Weinberg, “The Hazards of Iron Loading,” Metallomics, 2, no. 11 (November, 2010):732-40, DOI: 10.1039/c0mt00023j.

3. M. D. Beaton and P. C. Adams, “Treatment of Hyperferritinemia,” Annals of Hepatology, 11, no. 3 (2012): 294–300, PMID: 22481446.

4. G. Ortiz-Estrada et al., “Iron-Saturated Lactoferrin and Pathogenic Protozoa: Could This Protein Be an Iron Source for Their Parasitic Style of Life?” Future Microbiology, 7, no. 1 (2012): 149-64, DOI: 10.2217/fmb. 11.140.

5. D. J. Fleming et al., “Dietary Factors Associated with the Risk of High Iron Stores in the Elderly Framingham Heart Study Cohort,” American Journal of Clinical Nutrition, 76, no. 6 (2002): 1375-84, PMID: 12450906.

6. T. Iwasaki et al., “Serum Ferritin Is Associated with Visceral Fat Area and Subcutaneous Fat Area,” Diabetes Care, 28, no. 10 ("2005): 2486-91, PMID: 16186284.

7. S. К. Park et al., “Association between Serum Ferritin Levels and the Incidence of Obesity in Korean Men: A Prospective Cohort Study,” Endocrine Journal, 61, no. 3 (2014): 215-24, DOI: 10.1507/endocrj.EJ13-0173.

8. Там же.

9. J. M. Fernandez-Real et al., “Serum Ferritin as a Component of the Insulin Resistance Syndrome,” Diabetes Care, 21, no. 1 (1998): 62–68, DOI: 10.2337/dia-care.21.1.62.

10. }. Montonen et al., “Body Iron Stores and Risk of Type 2 Diabetes: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study,” Diabetologia, 55, no. 10 (2012): 2613-21, DOI: 10.1007/s00125-012-2633-y.

11. J. M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart, “Iron Stores, Blood Donation, and Insulin Sensitivity and Secretion,” Clinical Chemistry, 51, no. 7 (June 2005): 1201-5, DOI: 10.1373/clinchem.2004.046847.

12. B. J. Van Lenten et al., “Lipid-Induced Changes in Intracellular Iron Homeostasis in Vitro and in Vivo,” Journal of Clinical Investigation, 95, no. 5 (1995): 2104-10, DOI: 10.1172/JCI117898.

13. N. Stadler, R. A. Lindner, and M. J. Davies, “Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper,” Arteriosclerosis, Thrombosis, and Vascular Biology, 24 (2004): 949-54, DOI: 10.1161/01. ATV.0000124892.90999.cb.

14. W. B. Kannel et al., “Menopause and Risk of Cardiovascular Disease: The Framingham Study,” Annals of Internal Medicine, 85 (1976): 447-52, DOI: 10.7326/0003-4819-85-4-447.

15. M. A. Lovell et al., “Copper, Iron and Zinc in Alzheimer’s Disease Senile Plaques,” Journal of the Neurological Sciences, 158, no. 1 (June 11, 1998): 47–52, DOI: 10.1016/S0022-510X(98)00092-6.

16. K. Jellinger et al., “Brain Iron and Ferritin in Parkinsons and Alzheimer’s diseases,” Journal of Neural Transmission, 2 (1990): 327, DOI: 10.1007/BF02252926.

17. G. Bartzokis et al., “Brain Ferritin Iron as a Risk Factor for Age at Onset in Neuro-degenerative Diseases,” Annals of the New York Academy of Sciences, 1012,(2004): 224-36, DOI: 10.1196/annals.l306.019.

18. S. Ayton et al., “Ferritin Levels in the Cerebrospinal Fluid Predict Alzheimer’s Disease Outcomes and Are Regulated by APOE,” Nature Communications, 6 (2015): 6760, DOI: 10.1038/ncomms7760.

19. W. Z. Zhu et al., “Quantitative MR Phase-Corrected Imaging to Investigate Increased Brain Iron Deposition of Patients with Alzheimer’s Disease,” Radiology, 253 (2009): 497–504, DOI: 10.1148/radiol.2532082324.

20. A. A. Alkhateeb and J. R. Connor, “The Significance of Ferritin in Cancer: Anti-Oxidation, Inflammation and Tumorigenesis,” Biochimica et Biophysica Acta, 1836, no. 2 (Dec 2013):245-54, DOI: 10.1016/j.bbcan.2013.07.002.

21. J. I. Wurzelmann et al, “Iron Intake and the Risk of Colorectal Cancer,” Cancer Epidemiology, Biomarkers and Prevention, 5, no. 7 (July 1, 1996): 503-7. PMID: 8827353.

22. Y. Deugnier, “Iron and Liver Cancer,” Alcohol, 30, no. 2 (2003): 145-50.

23. L. R. Zacharski et al, “Decreased Cancer Risk after Iron Reduction in Patients with Peripheral Arterial Disease: Results from a Randomized Trial,” JNCI: Journal of National Cancer Institute, 100, no. 14 (2008): 996-1002, DOI: 10.1093/jnci/ djn209.

24. L. Valenti et al., “Association between Iron Overload and Osteoporosis in Patients with Hereditary Hemochromatosis,” Osteoporosis International, 20, no. 4 (April, 2009): 549-55, DOI: 10.1007/s00198-008-0701-4.

25. “Hemochromatosis,” National Institute of Diabetes and Digestive and Kidney Disease (2016), http://www.niddk.nih.gov/health-information/health-top-ics/liver-disease/hemochromatosis/Pages/facts.aspx, accessed May 9, 2016.

26. “Welcome,” Iron Disorders Institute (2016) http://www.hemochromatosis. org/#symptoms, accessed May 9, 2016.